CIK 0001157601 · Large accelerated filer
MADRIGAL PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- MDGL
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- (267) 824-2827
- Business address
- 1001 CONSHOHOCKEN STATE ROAD, SUITE 2-350, WEST CONSHOHOCKEN, PA
- Former names
- MADRIGAL PHARMACEUTICALS, INC., SYNTA PHARMACEUTICALS CORP
- Open-market buys, last 90 days
- $35,023,032
- in 1 filing
- Open-market sales, last 90 days
- $7,011,938
- in 3 filings, $6.7M under 10b5-1 plans
Net +$28,011,094. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-04-01 | Levy Richard S Director | Sale 10b5-1 | −3,900 | $256.88 | $1.0M | 13,011 |
| 2024-04-01 | Levy Richard S Director | Sale 10b5-1 | −1,600 | $257.93 | $413K | 11,411 |
| 2024-04-01 | Levy Richard S Director | Sale 10b5-1 | −100 | $259.07 | $26K | 11,311 |
| 2024-04-01 | Levy Richard S Director | Sale 10b5-1 | −713 | $265.28 | $189K | 10,598 |
| 2024-04-01 | Levy Richard S Director | Sale 10b5-1 | −300 | $267.07 | $80K | 10,298 |
| 2024-04-01 | Levy Richard S Director | Option exercise · Stock Option (Right to Buy) 10b5-1 | −5,000 | 15,000 | ||
| 2024-04-01 | Levy Richard S Director | Option exercise · Stock Option (Right to Buy) 10b5-1 | −6,000 | 0 | ||
| 2024-04-01 | BATE KENNETH Director | Option exercise 10b5-1 | +10,000 | $9.45 | $95K | 11,198 |
| 2024-04-01 | BATE KENNETH Director | Option exercise 10b5-1 | +10,000 | $100.45 | $1.0M | 21,198 |
| 2024-04-01 | BATE KENNETH Director | Option exercise 10b5-1 | +1,277 | $105.08 | $134K | 22,475 |
| 2024-04-01 | BATE KENNETH Director | Sale 10b5-1 | −6,698 | $255.62 | $1.7M | 15,777 |
| 2024-04-01 | BATE KENNETH Director | Sale 10b5-1 | −7,411 | $256.49 | $1.9M | 8,366 |
| 2024-04-01 | BATE KENNETH Director | Sale 10b5-1 | −2,790 | $257.33 | $718K | 5,576 |
| 2024-04-01 | BATE KENNETH Director | Sale 10b5-1 | −2,104 | $258.24 | $543K | 3,472 |
| 2024-04-01 | BATE KENNETH Director | Sale 10b5-1 | −200 | $259.13 | $52K | 3,272 |
| 2024-04-01 | BATE KENNETH Director | Sale 10b5-1 | −841 | $262.18 | $220K | 2,431 |
| 2024-04-01 | BATE KENNETH Director | Sale 10b5-1 | −143 | $263.08 | $38K | 2,288 |
| 2024-04-01 | BATE KENNETH Director | Sale 10b5-1 | −116 | $264.73 | $31K | 2,172 |
| 2024-04-01 | BATE KENNETH Director | Sale 10b5-1 | −700 | $265.36 | $186K | 1,472 |
| 2024-04-01 | BATE KENNETH Director | Sale 10b5-1 | −274 | $266.91 | $73K | 1,198 |
Page 35 of 82 · 1,629 trades